Opposing therapeutic efficacy of BET inhibitors is determined by cancer type-specific SPOP mutantsHana Janouskova,G. El Tekle,Namrata D. Udeshi,Anna Ulbricht,A. Rinaldi,Gianluca Civenni,Carlo V. Catapano,Matthias Peter,Steven A. Carr,Levi A. Garraway,Jean Philippe TheurillatEuropean Journal of Cancer(2016)引用 0|浏览34暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要